Suppr超能文献

胃肠病治疗中肥胖症的实用治疗模式。

A working paradigm for the treatment of obesity in gastrointestinal practice.

作者信息

Acosta Andres, Camilleri Michael

机构信息

Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

出版信息

Tech Gastrointest Endosc. 2017 Jan;19(1):52-60. doi: 10.1016/j.tgie.2017.01.003. Epub 2017 Jan 25.

Abstract

Obesity is a chronic, relapsing, multi-factorial disease characterized by abnormal or excessive adipose tissue accumulation that may impair health and increase disease risks. Despite the ever-increasing prevalence and economic and societal burden, the current approaches to treat obesity are not standardized or generally effective. In this manuscript, we describe a current working paradigm developed by a consensus approach for the multidisciplinary treatment of obesity in the GI practice. Obesity should be managed as a continuum of care focusing on weight loss, weight loss maintenance and prevention of weight regain. This approach needs to be disseminated throughout the health care system, coordinated by a multidisciplinary team and include gastroenterologists who are in a unique position to address obesity. Gastroenterologists are in the front line of managing the morbidity resulting from obesity, and have expertise in use of the essential tools to manage obesity: nutrition, pharmacology, endoscopy and surgery.

摘要

肥胖是一种慢性、复发性、多因素疾病,其特征是异常或过度的脂肪组织堆积,可能损害健康并增加疾病风险。尽管肥胖的患病率、经济和社会负担不断增加,但目前治疗肥胖的方法并不规范,也普遍效果不佳。在本手稿中,我们描述了一种通过共识方法制定的当前工作模式,用于胃肠病学实践中肥胖的多学科治疗。肥胖应作为一个连续的护理过程来管理,重点是体重减轻、体重减轻维持和预防体重反弹。这种方法需要在整个医疗保健系统中传播,由多学科团队协调,并包括处于独特地位来解决肥胖问题的胃肠病学家。胃肠病学家处于管理肥胖所致发病率的第一线,并且在使用管理肥胖的基本工具方面具有专业知识:营养、药理学、内窥镜检查和手术。

相似文献

1
A working paradigm for the treatment of obesity in gastrointestinal practice.
Tech Gastrointest Endosc. 2017 Jan;19(1):52-60. doi: 10.1016/j.tgie.2017.01.003. Epub 2017 Jan 25.
2
White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources.
Clin Gastroenterol Hepatol. 2017 May;15(5):631-649.e10. doi: 10.1016/j.cgh.2016.10.023. Epub 2017 Feb 27.
3
Feeding the critically ill obese patient: a systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Oct;13(10):95-109. doi: 10.11124/jbisrir-2015-2458.
5
Towards a multidisciplinary approach to understand and manage obesity and related diseases.
Clin Nutr. 2017 Aug;36(4):917-938. doi: 10.1016/j.clnu.2016.11.007. Epub 2016 Nov 16.
7
Medical devices for the treatment of obesity.
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):553-564. doi: 10.1038/nrgastro.2017.80. Epub 2017 Jul 12.
8
American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.
Gastroenterology. 2020 Jan;158(1):67-75.e1. doi: 10.1053/j.gastro.2019.07.064. Epub 2019 Aug 31.
9
The Minderoo-Monaco Commission on Plastics and Human Health.
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.

引用本文的文献

1
Appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion as treatment for obesity in primary care.
Obes Pillars. 2025 Feb 26;14:100170. doi: 10.1016/j.obpill.2025.100170. eCollection 2025 Jun.
3
Identifying obesogenic environment through spatial clustering of body mass index among adults.
Int J Health Geogr. 2024 Jun 26;23(1):16. doi: 10.1186/s12942-024-00376-5.
4
The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.
Diabetes Obes Metab. 2024 Apr;26 Suppl 2(Suppl 2):46-63. doi: 10.1111/dom.15555. Epub 2024 Mar 19.
5
The perceived role of food and eating among turkish women with obesity: A qualitative analysis.
Curr Psychol. 2022 Oct 22:1-12. doi: 10.1007/s12144-022-03778-5.
6
Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study.
Gut. 2023 Jun;72(6):1073-1080. doi: 10.1136/gutjnl-2022-327816. Epub 2022 Oct 14.
7
Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications.
Obesity (Silver Spring). 2021 Feb;29(2):265-273. doi: 10.1002/oby.23068.
8
Intermittent Fasting and Metabolic Health: From Religious Fast to Time-Restricted Feeding.
Obesity (Silver Spring). 2020 Jul;28 Suppl 1(Suppl 1):S29-S37. doi: 10.1002/oby.22829.
9
Adipogenesis Regulation and Endocrine Disruptors: Emerging Insights in Obesity.
Biomed Res Int. 2020 Feb 18;2020:7453786. doi: 10.1155/2020/7453786. eCollection 2020.

本文引用的文献

1
White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources.
Clin Gastroenterol Hepatol. 2017 May;15(5):631-649.e10. doi: 10.1016/j.cgh.2016.10.023. Epub 2017 Feb 27.
2
Pharmacotherapy for Obesity.
Endocrinol Metab Clin North Am. 2016 Sep;45(3):521-38. doi: 10.1016/j.ecl.2016.04.005.
6
Updating ACSM's Recommendations for Exercise Preparticipation Health Screening.
Med Sci Sports Exerc. 2015 Nov;47(11):2473-9. doi: 10.1249/MSS.0000000000000664.
7
Efficacy of Commercial Weight-Loss Programs.
Ann Intern Med. 2015 Sep 1;163(5):399. doi: 10.7326/L15-5130-3.
8
Gastrointestinal traits: individualizing therapy for obesity with drugs and devices.
Gastrointest Endosc. 2016 Jan;83(1):48-56. doi: 10.1016/j.gie.2015.08.007. Epub 2015 Aug 10.
10
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验